Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist (2021)

First Author: Pickford P

Attributed to: Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.03.02.433157

Publication URI: http://dx.doi.org/10.1101/2021.03.02.433157

Type: Preprint